University of Mississippi School of Pharmacy
iForumRx.org
This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the evidence regarding drug therapy and patient management.
Be sure to visit the podcast's website and support the creator: iforumrx.podbean.com
Author
University of Mississippi School of Pharmacy
Category
Podcast website
Latest episode
Nov 6, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Sequential Additions or Multicomponent Combination? Should Our Approach to Hypertension Be Re-examined? 11.03.2022 19:08
Traditionally, hypertension management involves a stepwise approach where agents are titrated and added. Thus, achieving optimal BP control requires close follow-up, time, and resources. Outside of these logistics, providers are prone to clinical inertia (aka fail to advance therapy when they should) and sometimes “push back” from patients who experience the burdens of treatment and follow-up. Pe...
Extra Protection? Finerenone Use in Patients with Type 2 DM and CKD 01.03.2022 20:17
Despite prevention efforts, about 1 in 3 patients diagnosed with diabetes have comorbid CKD. Half of these individuals have moderate to severe disease. Unlike patients with type 1 diabetes where it develops after many years after the diagnosis, CKD is commonly present at diagnosis in patients with type 2 diabetes. While many interventions are available to prevent the progression of CKD, more are n...
Assessing HER Acceptability of Contraception 09.02.2022 15:18
More than half of women in the United States aged 15 to 49 years use a form of contraception. However, many women discontinue use during the first 12 months. Reasons for discontinuation include inconvenience, method failure, adverse effects, and cost. But another potential factor that is not as well-studied is the sexual acceptability of the contraceptive method. Guest Authors: Katherine Harte, P...
Preserving hope for patients with Heart Failure with Preserved Ejection Fraction (HFpEF)? 14.01.2022 21:37
Although guideline-directed medical therapy substantially improves morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF), treatments that clearly improve outcomes in those with HF and an EF >40% remain elusive. Unfortunately, the incidence and prevalence of HF are expected to substantially increase in the coming decades. More evidence and effective treatmen...
Top Ten Things Every Clinician Should Know about Continuous Glucose Monitors (CGM) 31.12.2021 21:13
Continuous glucose monitors (CGMs) are now commonplace, and every clinician should know the basics about who can benefit from CGM use and how to address common questions and problems. Authors: Brianna Patacini, PharmD, BCACP, CDCES and Dawn Fuke, PharmD, BCPS Special Guest: Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM Music by Good Talk
Spice Up Your Sleep Life with Saffron 19.12.2021 18:13
Every day, millions suffer from poor sleep that disrupts their lives, and long-term sleep disorders can cause attention deficits, mood disorders, anxiety, and depression. Several prescription treatment options for sleep are available but they often have undesirable side effects and can lead to tolerance and dependency. Thus, a natural product that has been documented to improve sleep with minimal...
Will a Dual GIP/GLP-1 Receptor Agonist SURPASS the Crowd? 03.12.2021 27:47
There are now over 30 unique therapeutic entities (and countless different products!) to treat hyperglycemia in patients with type 2 diabetes mellitus (T2DM). While the glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control, renal, and cardiovascular outcomes and induce significant weight loss, drugs that target more than one incretin hormone may have even greater therapeutic...
Cut It Out! Removing EHR Allergy Warnings to Improve Antimicrobial Stewardship 12.11.2021 16:13
WARNING: Patient has a penicillin allergy! Do you want to continue with this cephalexin order? Although these warnings are commonplace, immunologic cross-reactivity between penicillins and cephalosporins is uncommon. When B-lactams are indicated as first-line therapy for therapy, cephalosporins are often avoided if the patient has a penicillin allergy listed. Would the removal of EHR warnings abou...
What’s the Right Dose of Aspirin in Patients with Heart Disease? 29.10.2021 17:36
There is no consensus regarding the preferred dosage of aspirin in patients with atherosclerotic cardiovascular disease (ASCVD) and this has led to variability in prescribing patterns. This is likely due to the lack of head-to-head trials evaluating different aspirin doses and data weighing the clinical benefits and adverse effects experienced with aspirin. Until now? Guest Authors: Ivy Nwogu, Pha...
Bursting the Steroid Bubble: Short-term Use Has Its Consequences 15.10.2021 19:07
Short courses of corticosteroids, also known as “steroid bursts,” are frequently utilized in both pediatrics and adults; however, evidence supporting the safety of these bursts is lacking. Long-term use of oral corticosteroids is associated with a number of serious adverse effects. New evidence suggests that a steroid burst is not risk-free. Guest Authors: Irene Ruiz, PharmD and Kristine A. Parb...
Guiding Antiplatelet Therapy: Is a Personalized Approach Worth It? 05.10.2021 19:58
Variability in clopidogrel pharmacokinetics among patients has been appreciated for years and this results in inconsistent effects on platelet inhibition and poor outcomes. Multiple strategies to personalize antiplatelet therapy intended to balance the risks and benefits of therapy have been tested. A recent systematic review and meta-analysis attempts to answer the question: Is a personalized app...
Psilocybin for Depression: Is it Worth the Trip? 17.09.2021 18:57
Although there are numerous medications available to treat major depressive disorder, not all patients respond, and some experience intolerable side effects. Thus, we need to find and develop new treatment options. There has been considerable interest in psychedelic compounds that may have antidepressant activity. Recent research using psychedelics for mental health conditions has made news headli...
Up the Creek Without a Paddle? Look to Your Pharmacist to Bridge-It 31.08.2021 22:07
Nearly half of all pregnancies are unintended and a high percentage of unwanted pregnancies lead to an abortion. Reducing the number of unintended pregnancies and increasing the use of effective birth control are two public health priorities. Could the implementation of pharmacist contraception prescribing combined with EC on the same day help “bridge the gap?” Guest Authors: Ashley H. Meredith,...
SGLT2i plus MRAs for Heart Failure: A Sweet or Sour Combination? 13.08.2021 17:26
We now have “diabetes medications” to treat heart failure with reduced ejection practice (HFrEF). Many clinicians have not yet used a sodium-glucose transporter 2 inhibitor (SGLT2i) for the treatment of HF and are (rightfully) concerned about potential drug-drug interactions, particularly when using an SGTL2i with a mineralocorticoid (MRA). A recent secondary analysis using data from the EMPEROR-R...
Is As-Needed Nasal Corticosteroid Use Needed for Allergic Rhinitis Management? 30.07.2021 17:33
Allergic rhinitis affects millions of children and adults. Indeed, it is the fifth most common chronic disease in the United States. Although people do not die from allergic rhinitis, it sure can make you feel miserable, disturb sleep, and impair daily activities. Guidelines recommend the use of intranasal corticosteroids on a daily basis since the onset of action takes a few days. In reality, ho...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.